Ubs Group Ag Novartis Ag Transaction History

Ubs Group Ag

$528 Billion
Q1 2025

A detailed history of Ubs Group Ag transactions in Novartis Ag stock. As of the latest transaction made, Ubs Group Ag holds 1,703,702 shares of NVS stock, worth $197 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares

1,703,702

Previous 1,697,511 0.36%

Holding current value

$197 Million

Previous $165 Million 14.98%

% of portfolio

0.04%

Previous 0.03%

34 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 13, 2025	BUY	$97.14 - $115.57 $601,393 - $715,493	6,191 Added 0.36%	1,703,702 $190 Million
Q4 2024 Feb 14, 2025	BUY	$96.78 - $117.18 $31.7 Million - $38.4 Million	327,690 Added 23.92%	1,697,511 $165 Million
Q3 2024 Nov 14, 2024	SELL	$106.13 - $120.89 $1.4 Million - $1.6 Million	-13,225 Reduced 0.96%	1,369,821 $158 Million
Q2 2024 Aug 13, 2024	SELL	$92.57 - $107.37 $15.2 Million - $17.6 Million	-163,692 Reduced 10.58%	1,383,046 $147 Million
Q1 2024 May 13, 2024	SELL	$95.27 - $108.47 $10.9 Million - $12.4 Million	-114,754 Reduced 6.91%	1,546,738 $150 Million
Q4 2023 Feb 09, 2024	SELL	$92.27 - $101.54 $18 Million - $19.8 Million	-195,165 Reduced 10.51%	1,661,492 $168 Million
Q3 2023 Nov 09, 2023	BUY	$94.73 - $105.13 $5.53 Million - $6.14 Million	58,406 Added 3.25%	1,856,657 $189 Million
Q2 2023 Aug 11, 2023	SELL	$92.52 - $104.91 $8.03 Million - $9.11 Million	-86,831 Reduced 4.61%	1,798,251 $181 Million
Q1 2023 May 12, 2023	SELL	$80.03 - $92.81 $16 Million - $18.5 Million	-199,411 Reduced 9.57%	1,885,082 $173 Million
Q4 2022 Feb 08, 2023	SELL	$75.55 - $92.52 $19.5 Million - $23.9 Million	-258,530 Reduced 11.03%	2,084,493 $189 Million
Q3 2022 Nov 10, 2022	SELL	$74.61 - $87.26 $19.6 Million - $23 Million	-263,265 Reduced 10.1%	2,343,023 $178 Million
Q2 2022 Aug 10, 2022	SELL	$80.52 - $93.75 $46 Million - $53.5 Million	-570,793 Reduced 17.97%	2,606,288 $220 Million
Q1 2022 May 16, 2022	SELL	$80.11 - $90.62 $80.3 Million - $90.8 Million	-1,001,819 Reduced 23.97%	3,177,081 $279 Million
Q4 2021 Feb 14, 2022	SELL	$79.7 - $88.13 $26.4 Million - $29.2 Million	-331,179 Reduced 7.34%	4,178,900 $366 Million
Q3 2021 Nov 15, 2021	SELL	$81.78 - $95.14 $20.4 Million - $23.8 Million	-249,657 Reduced 5.25%	4,510,079 $369 Million
Q2 2021 Aug 13, 2021	SELL	$85.24 - $94.15 $23.2 Million - $25.6 Million	-271,730 Reduced 5.4%	4,759,736 $434 Million
Q1 2021 May 12, 2021	SELL	$83.5 - $98.47 $41 Million - $48.4 Million	-491,485 Reduced 8.9%	5,031,466 $430 Million
Q4 2020 Feb 11, 2021	SELL	$78.07 - $94.43 $88.2 Million - $107 Million	-1,129,253 Reduced 16.98%	5,522,951 $522 Million
Q3 2020 Nov 12, 2020	SELL	$82.14 - $91.0 $8.18 Million - $9.06 Million	-99,529 Reduced 1.47%	6,652,204 $578 Million
Q2 2020 Jul 31, 2020	SELL	$80.93 - $91.1 $52.5 Million - $59.1 Million	-649,131 Reduced 8.77%	6,751,733 $590 Million
Q1 2020 May 01, 2020	SELL	$70.67 - $99.01 $48.3 Million - $67.6 Million	-682,943 Reduced 8.45%	7,400,864 $610 Million
Q4 2019 Feb 14, 2020	BUY	$84.35 - $95.37 $39.4 Million - $44.5 Million	467,073 Added 6.13%	8,083,807 $765 Million
Q3 2019 Nov 14, 2019	SELL	$85.54 - $94.26 $17.9 Million - $19.8 Million	-209,843 Reduced 2.68%	7,616,734 $662 Million
Q2 2019 Aug 14, 2019	BUY	$75.4 - $92.8 $55.3 Million - $68 Million	733,274 Added 10.34%	7,826,577 $715 Million
Q1 2019 May 14, 2019	BUY	$75.32 - $86.15 $21.2 Million - $24.2 Million	280,956 Added 4.12%	7,093,303 $682 Million
Q4 2018 Feb 14, 2019	BUY	$73.66 - $82.02 $10.1 Million - $11.3 Million	137,627 Added 2.06%	6,812,347 $585 Million
Q3 2018 Nov 14, 2018	BUY	$66.94 - $77.43 $6.73 Million - $7.78 Million	100,504 Added 1.53%	6,674,720 $575 Million
Q2 2018 Aug 14, 2018	BUY	$64.91 - $73.36 $3.34 Million - $3.77 Million	51,439 Added 0.79%	6,574,216 $497 Million
Q1 2018 May 15, 2018	BUY	$70.39 - $84.15 $20.6 Million - $24.6 Million	292,268 Added 4.69%	6,522,777 $527 Million
Q4 2017 Feb 14, 2018	BUY	$72.33 - $77.64 $5.84 Million - $6.27 Million	80,782 Added 1.31%	6,230,509 $523 Million
Q3 2017 Nov 14, 2017	SELL	$74.14 - $77.27 $4.73 Million - $4.93 Million	-63,784 Reduced 1.03%	6,149,727 $528 Million
Q2 2017 Nov 14, 2017	BUY	N/A	4,350 Added 0.07%	6,213,511 $519 Million
Q2 2017 Aug 14, 2017	BUY	N/A	212,060 Added 3.54%	6,209,161 $518 Million
Q1 2017 Nov 14, 2017	BUY	N/A	5,997,101	5,997,101 $445 Million

Others Institutions Holding NVS

# of Institutions

1,524

Shares Held

142M

Call Options Held

1.63M

Put Options Held

1.82M

View Full List

About NOVARTIS AG

Ticker NVS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,151,000,064
Market Cap $249B
Description
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...

More about NVS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Group Ag with notifications on news.

Account